Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
Open-market buys, last 90 days
$35,023,032
in 1 filing
Open-market sales, last 90 days
$7,011,938
in 3 filings, $6.7M under 10b5-1 plans

Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. BAKER BROS. ADVISORS LP +$35.0M Director 1 filing
  2. Sibold William John −$6.2M President and CEO sold 6% of stake
  3. Kelley Shannon T −$773K General Counsel sold 14% of stake
Date Insider Transaction Shares Price Value Owned after
2023-12-04 Lynch Brian Joseph SVP and General Counsel Option exercise · Stock Option (Right to Buy) −800 20,200
2023-12-04 Lynch Brian Joseph SVP and General Counsel Option exercise · Stock Option (Right to Buy) −1,000 44,000
2023-11-30 Lynch Brian Joseph SVP and General Counsel Option exercise +3,000 $73.75 $221K 18,001
2023-11-30 Lynch Brian Joseph SVP and General Counsel Sale −1,000 $204.00 $204K 17,001
2023-11-30 Lynch Brian Joseph SVP and General Counsel Sale −1,000 $203.00 $203K 16,001
2023-11-30 Lynch Brian Joseph SVP and General Counsel Sale −1,000 $206.73 $207K 15,001
2023-11-30 Lynch Brian Joseph SVP and General Counsel Option exercise · Stock Option (Right to Buy) −3,000 18,000
2023-11-29 Lynch Brian Joseph SVP and General Counsel Option exercise +4,000 $73.75 $295K 19,001
2023-11-29 Lynch Brian Joseph SVP and General Counsel Sale −1,000 $198.40 $198K 18,001
2023-11-29 Lynch Brian Joseph SVP and General Counsel Sale −3,000 $199.45 $598K 15,001
2023-11-29 Lynch Brian Joseph SVP and General Counsel Option exercise · Stock Option (Right to Buy) −4,000 21,000
2023-11-21 BAKER BROS. ADVISORS LP Director Purchase +12 $185.94 $2K 171,006
2023-11-21 BAKER BROS. ADVISORS LP Director Purchase +146 $185.94 $27K 1,607,814
2023-11-21 BAKER BROS. ADVISORS LP Director Purchase +31 $183.16 $6K 171,037
2023-11-21 BAKER BROS. ADVISORS LP Director Purchase +369 $183.16 $68K 1,608,183
2023-11-21 BAKER BROS. ADVISORS LP Director Purchase +53 $186.32 $10K 171,090
2023-11-21 BAKER BROS. ADVISORS LP Director Purchase +647 $186.32 $121K 1,608,830
2023-11-21 BAKER BROS. ADVISORS LP Director Purchase +115 $186.59 $21K 171,205
2023-11-21 BAKER BROS. ADVISORS LP Director Purchase +1,385 $186.59 $258K 1,610,215
2023-11-21 BAKER BROS. ADVISORS LP Director Purchase +176 $187.24 $33K 171,381

Page 42 of 82 · 1,629 trades